Hui‐Chuan Sun

1999–2026 年に発表

別表記
HUI-CHUAN SUN
144
論文数
18,267
被引用数
75
h 指数
129
i10 指数

被引用数

Hui‐Chuan Sun の年別被引用数1939 年: 被引用 1 件1979 年: 被引用 1 件1991 年: 被引用 1 件2000 年: 被引用 2 件2001 年: 被引用 7 件2002 年: 被引用 4 件2003 年: 被引用 7 件2004 年: 被引用 13 件2005 年: 被引用 10 件2006 年: 被引用 17 件2007 年: 被引用 28 件2008 年: 被引用 42 件2009 年: 被引用 49 件2010 年: 被引用 78 件2011 年: 被引用 102 件2012 年: 被引用 116 件2013 年: 被引用 141 件2014 年: 被引用 131 件2015 年: 被引用 131 件2016 年: 被引用 94 件2017 年: 被引用 132 件2018 年: 被引用 106 件2019 年: 被引用 517 件2020 年: 被引用 712 件2021 年: 被引用 740 件2022 年: 被引用 762 件2023 年: 被引用 672 件2024 年: 被引用 1,338 件2025 年: 被引用 754 件2026 年: 被引用 82 件1940〜1978 年は被引用が無いため表示していません1980〜1990 年は被引用が無いため表示していません1992〜1999 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図中国: 引用元論文 3,646 件、この内訳の 45.2%アメリカ合衆国: 引用元論文 1,114 件、この内訳の 13.8%イタリア: 引用元論文 254 件、この内訳の 3.1%日本: 引用元論文 244 件、この内訳の 3%ドイツ: 引用元論文 232 件、この内訳の 2.9%イギリス: 引用元論文 199 件、この内訳の 2.5%香港: 引用元論文 188 件、この内訳の 2.3%韓国: 引用元論文 180 件、この内訳の 2.2%フランス: 引用元論文 145 件、この内訳の 1.8%インド: 引用元論文 138 件、この内訳の 1.7%スペイン: 引用元論文 121 件、この内訳の 1.5%エチオピア: 引用元論文 121 件、この内訳の 1.5%
0%45.2%その他 18.5%

分野

  • Medicine47.2%
  • Biochemistry, Genetics and Molecular Biology36.7%
  • Immunology and Microbiology10.2%
  • Computer Science1.9%
  • Chemistry1.1%
  • Engineering0.9%
  • その他2%

トピック

  • Hepatocellular Carcinoma Treatment and Prognosis9.1%
  • Cholangiocarcinoma and Gallbladder Cancer Studies4.3%
  • MicroRNA in disease regulation4%
  • Immune cells in cancer3.8%
  • Cancer Immunotherapy and Biomarkers3.7%
  • Cancer-related molecular mechanisms research3.4%
  • その他71.7%

共著者

全論文

検索で開く
  1. Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yaguang Zhang, Shiping Liu, Xin‐Rong Yang, Jia Fan - Cell 2020 被引用: 957

  2. Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rudolf Stauber, Matthias Pinter, Markus Peck‐Radosavljevic, Jochen Decaestecker, Pieter‐Jan Cuyle, Gontran Verset, Hans Van Vlierberghe, Sérgio de Azevedo, Livia Andrade, Ademar Cunha Júnior, Luiza Dib Batista Bugiato Faria, Cheng Tzu Yen, Leandro M. Colli, Jamil Asselah, Petr Kavan, Vladimir Marquez, Mayur Brahmania, Qiang Li, Bao-Cai Xing, Yabing Guo, Zhendong Chen, Haitao Zhao, Tao Peng, Liming Wang, Lu Wang, Hongming Liu, Feixiang Wu, Lun–Xiu Qin, Qichang Zheng, Jieer Ying, Haitao Li, Tianfu Wen, Shukui Qin, Xiaoyu Wen, Yunpeng Liu, Minshan Chen, Boqing Wang, Yuxian Bai, Yifu He, Hong Zhao, Dong Zhou, Chaoliu Dai, Gao‐Jun Teng, Shuzhong Cui, Yi Gao, Xizhi Zhang, Zheng Lu, Tao Yin, Youming Ding, Weidong Jia, Yongxiang Xia, Beicheng Sun, Qiang Xia, Yufeng Yuan, Hui‐Chuan Sun, Xuetao Shi, A. Guzmán, Luis Corrales, Zdeněk Král, Peter Priester, Eugen Kubala, Jean Frédéric Blanc, Marc Bourlière, Jean Marie Péron, Christophe Borg, Jean–Pierre Bronowicki, Nathalie Ganne, Thomas Decaens, Thomas Uguen, Alexandra Heurgué ほか 109 名 - The Lancet 2023 被引用: 488

  3. Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Baojin Hua, Xiaowu Huang, Weidong Jia, Yaming Li, Ye‐Xiong Li, Jun Liang, Tianshu Liu, Guoyue Lv, Yilei Mao, Tao Peng, Weixin Ren, Hongcheng Shi, Guo‐Ming Shi, Kaishan Tao, Wentao Wang, Xiaoying Wang, Zhiming Wang, Bang‐De Xiang, Baocai Xing, Jianming Xu, Jiamei Yang, Jianyong Yang, Yefa Yang, Yunke Yang, Sheng‐Long Ye, Zhengyu Yin, Bixiang Zhang, Boheng Zhang, Leida Zhang, Shuijun Zhang, Ti Zhang, Yongfu Zhao, Honggang Zheng, Jiye Zhu, Kangshun Zhu, Rong Liu, Ying–Hong Shi, Yong‐Sheng Xiao, Zhi Dai, Gao‐Jun Teng, Jianqiang Cai, Weilin Wang, Xiujun Cai, Qiang Li, Feng Shen, Shukui Qin, Jiahong Dong, Jia Fan - Liver Cancer 2020 被引用: 833

  4. Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Zhenyu Wu, Tieliu Shi, Weimin Zhu, Jun Qin, Lu Xie, Jia Fan, Xiaohong Qian, Fuchu He - Nature 2019 被引用: 990

  5. Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Shuqun Cheng, Chaoliu Dai, Wenzhi Guo, Yabing Guo, Baojin Hua, Xiaowu Huang, Weidong Jia, Qiu Li, Tao Li, Xun Li, Yaming Li, Ye‐Xiong Li, Jun Liang, Changquan Ling, Tianshu Liu, Xiufeng Liu, Shichun Lu, Guoyue Lv, Yilei Mao, Zhiqiang Meng, Tao Peng, Weixin Ren, Hongcheng Shi, Guo‐Ming Shi, Ming Shi, Tianqiang Song, Kaishan Tao, Jianhua Wang, Kui Wang, Lu Wang, Wentao Wang, Xiaoying Wang, Zhiming Wang, Bang‐De Xiang, Baocai Xing, Jianming Xu, Jiamei Yang, Yang Jianyong, Yefa Yang, Yunke Yang, Sheng‐Long Ye, Zhen‐Yu Yin, Yong Zeng, Bixiang Zhang, Boheng Zhang, Leida Zhang, Shuijun Zhang, Ti Zhang, Yanqiao Zhang, Ming Zhao, Yongfu Zhao, Honggang Zheng, Ledu Zhou, Jiye Zhu, Kangshun Zhu, Rong Liu, Ying–Hong Shi, Yong‐Sheng Xiao, Lan Zhang, Chun Yang, Zhifeng Wu, Zhi Dai, Minshan Chen, Jianqiang Cai, Weilin Wang, Xiujun Cai, Q. Li, Feng Shen, Shukui Qin, Gao‐Jun Teng ほか 2 名 - Liver Cancer 2023 被引用: 452

  6. Ovis2.5 Technical Report

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Shengze Shi, Weihong Zhang, Guodong Zheng, Jun Jiang, Gao, Sensen, Yifeng Wu, Sijia Chen, Yuhui Chen, Qing-Guo Chen, Xu Zhao, Weihua Luo, Zhang, Kaifu - ArXiv.org, CoRR 2025 被引用: 97

  7. Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eric X. Chen, Ying Cheng, Antonio Cubillo Gracián, Laëtitia Dahan, Filippo de Braud, Elisabetta Fenocchio, Olumide Gbolohon, Roopinder Gillmore, Marine Jary, Milind Javle, Yixing Jiang, Jung Hun Kang, Gentry George King, Madappa N. Kundranda, Laura Layos, Daneng Li, Tingbo Liang, Sara Lonardi, Omkar Marathe, Sebastián Mondaca, Andrés J. Muñoz Martín, Joon Oh Park, Roberto Pazo-Cid, Paula Ribera Fernandez, Lorenza Rimassa, Rosa Alonso, Saeed Sadeghi, Aaron J. Scott, Benjamin Tan, David Tougeron, Qiang Yan, Xiaoyu Yin, Haitao Zhao - The Lancet Oncology 2023 被引用: 247

  8. IFNα Potentiates Anti–PD-1 Efficacy by Remodeling Glucose Metabolism in the Hepatocellular Carcinoma Microenvironment

    著者: , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2022 被引用: 205

  9. Dissecting spatial heterogeneity and the immune-evasion mechanism of CTCs by single-cell RNA-seq in hepatocellular carcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yong Hou, Jia Fan, Xin‐Rong Yang - Nature Communications 2021 被引用: 215

  10. Tumor associated macrophages-derived exosomes facilitate hepatocellular carcinoma malignance by transferring lncMMPA to tumor cells and activating glycolysis pathway

    著者: , , , , , , , , , , - Journal of Experimental & Clinical Cancer Research 2022 被引用: 136

  11. Integrated multi-omics profiling to dissect the spatiotemporal evolution of metastatic hepatocellular carcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jian Zhou, Xingxu Huang, David H. Peng, Liye Zhang, Jia Fan - Cancer Cell 2023 被引用: 109

  12. Downstaging and Resection of Initially Unresectable Hepatocellular Carcinoma with Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody Combinations

    著者: , , , , , , , , , , , , , , - Liver Cancer 2021 被引用: 237

  13. Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Shichun Lu, Zheng Lu, Wei‐Fu Lv, Yilei Mao, Guoliang Shao, Ying‐Hong Shi, Tianqiang Song, Guang Tan, Yunqiang Tang, Kaishan Tao, Chidan Wan, Guangyi Wang, Lu Wang, Shunxiang Wang, Tianfu Wen, Baocai Xing, Bang‐De Xiang, Sheng Yan, Dinghua Yang, Guowen Yin, Tao Yin, Zhenyu Yin, Zhengping Yu, Bixiang Zhang, Jialin Zhang, Shuijun Zhang, Ti Zhang, Yamin Zhang, Yubao Zhang, Aibin Zhang, Haitao Zhao, Ledu Zhou, Wu Zhang, Zhenyu Zhu, Shukui Qin, Feng Shen, Xiujun Cai, Gao‐Jun Teng, Jianqiang Cai, Minshan Chen, Qiang Li, Lianxin Liu, Weilin Wang, Tingbo Liang, Jiahong Dong, Xiaoping Chen, Xuehao Wang, Shusen Zheng, Jia Fan - HepatoBiliary Surgery and Nutrition 2022 被引用: 198

  14. The lncRNA NEAT1 activates Wnt/β-catenin signaling and promotes colorectal cancer progression via interacting with DDX5

    著者: , , , , , , , , , , - Journal of Hematology & Oncology 2018 被引用: 368

  15. Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Guoyue Lv, Yi-Lei Mao, Wei-Xin Ren, Hong-Cheng Shi, Wen-Tao Wang, Xiaoying Wang, Bao-Cai Xing, Jian-Ming Xu, Jian-Yong Yang, Ye-Fa Yang, Sheng-Long Ye, Zheng-Yu Yin, Bo-Heng Zhang, Shui-jun Zhang, Wei-Ping Zhou, Ji-Ye Zhu, Rong Liu, Ying-Hong Shi, Yong-Sheng Xiao, Zhi Dai, Gao‐Jun Teng, Jian-qiang Cai, Wei–Lin Wang, Jiahong Dong, Qiang Li, Feng Shen, Shu-Kui Qin, Jia Fan - Liver Cancer 2018 被引用: 688

  16. Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 study

    著者: , , , , , , , , , , , , , , , , , , , , , , - Signal Transduction and Targeted Therapy 2023 被引用: 148

  17. Adjuvant Transarterial Chemoembolization for HBV-Related Hepatocellular Carcinoma After Resection: A Randomized Controlled Study

    著者: , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2018 被引用: 348

  18. Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Wan Yee Lau, Chuan He, Hongyang Wang, Wei Zhang, Jia Fan - Gut 2019 被引用: 293

  19. Colony-Stimulating Factor 1 Receptor Blockade Inhibits Tumor Growth by Altering the Polarization of Tumor-Associated Macrophages in Hepatocellular Carcinoma

    著者: , , , , , , , , , , - Molecular Cancer Therapeutics 2017 被引用: 174

  20. Neoadjuvant Three-Dimensional Conformal Radiotherapy for Resectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Randomized, Open-Label, Multicenter Controlled Study

    著者: , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 被引用: 280

  21. Hepatectomy After Conversion Therapy Using Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibody Therapy for Patients with Unresectable Hepatocellular Carcinoma

    著者: , , , , , , , , , , , , , , - Annals of Surgical Oncology 2022 被引用: 72

  22. Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Zhiqiang Meng, Feng Shen, Jie Shi, Hui‐Chuan Sun, Kaishan Tao, Gao‐Jun Teng, Xuying Wan, Tianfu Wen, Liqun Wu, Jinglin Xia, Mingang Ying, Jian Zhai, Leida Zhang, Xuewen Zhang, Zhiwei Zhang, Haiping Zhao, Donghai Zheng, Xu–Ting Zhi, Jie Zhou, Cuncai Zhou, Jian Zhou, Zhao‐Chong Zeng, Kangshun Zhu, Minshan Chen, Jianqiang Cai, Shuqun Cheng - Liver Cancer 2022 被引用: 110

  23. Distinct single-cell immune ecosystems distinguish true and de novo HBV-related hepatocellular carcinoma recurrences

    著者: , , , , , , , , , , , , , , , , , , , , , - Gut 2023 被引用: 67

  24. Tumor Radiomic Features on Pretreatment MRI to Predict Response to Lenvatinib plus an Anti-PD-1 Antibody in Advanced Hepatocellular Carcinoma: A Multicenter Study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Liver Cancer 2022 被引用: 49